Python for the Life Sciences

1. Getting Started with Python.- 2. Python at the Lab Bench.- 3. Making Sense of Sequences.- 4. A Statistical Interlude.- 5. Open Doors to your Data.- 6. Finding Needles in Haystacks.- 7. Object Lessons.- 8. Slicing and Dicing Genomic Data.- 9. The Wells! The Wells!.- 10. Well on the Way.- 11. Molecules in 3D.- 12. Turning Genes on and off.- 13. Taming the Network Hairball.- 14. Genetic Feedback Loops.- 15. Growing a Virtual Garden.- 16. How the Leopard got its Spots.- 17. Foxes Guarding Hen Houses.- 18. A Virtual Flu Epidemic.- 19. Retracing Life's Footsteps.

Alex Lancaster is an evolutionary biologist, engineer, writer and consultant. Alex completed his Ph.D. in evolutionary biology at the University of California, Berkeley, and also holds bachelor's degrees in physics and electrical engineering. He has worked in research & development in both Australia and the United States with a major focus on evolutionary and systems biology. He has also worked extensively in genomics, analyzing next-generation sequencing data and has developed tools for clinical and population genomics, with a particular specialization in immunogenetic applications. He has held research and faculty positions in academia, as well as R&D positions in the broadcasting and IT industries.
Alex has published many peer-reviewed papers and is interested in solving problems in biology using evolutionary and complex adaptive systems approaches. He has done pioneering work in this area as a co-developer of the open-source agent-based modeling toolkit, Swarm,one of the first tools for large-scale modeling of collective behavior in biology and beyond. He is passionate about the power of open source and open science approaches to accelerate discovery.

Gordon Webster has a PhD in biophysics and structural biology from the University of London, Gordon has worked in life science R&D in both Europe and the U.S., with a particular emphasis on molecular engineering and computational biology. In academic and commercial environments ranging from universities and medical schools to small venture capital-funded startups and global pharmaceutical companies, he has served in a diversity of roles from research faculty to company vice president.
Gordon is the author of numerous original scientific articles and patents and has created and managed some very successful research partnerships with industrial, academic and government organizations. He initiated and managed the first translational oncology clinical trial at a multinational